Insights On Clinical Technologies

  1. CDS: Who We Are, What We Do, And How We're Different 2/26/2024

    In this segment from Clinical Leader's Solutions Expo: EDC Showcase, Brian Dufresne, SVP of Business Development at CDS delves into who CDS is, what they do, how they're different, and also what their TrialKit has to offer.

  2. Customer Testimonial – Chuck Bradley, Clinical Development & Operations Consultant 6/26/2024

    In this testimonial, a Clinical Development & Operations Consultant highlights the industry-standard Medidata platform and the significant benefits of using a consistent system across sites.

  3. Regional Comparisons Of Pharmaceutical Regulations 12/18/2023

    Uncover how performance and regulatory expectations differ for regulatory agencies in various markets, influenced by regional drug review trends, approval decisions, and regulatory guidance.

  4. Transforming Regulatory Processes Through AI, ML, NLP, And RPAs 4/7/2025

    Explore the rapidly evolving landscape of regulatory processes as they undergo a profound digital transformation, highlighting how emerging technologies are reshaping traditional regulatory frameworks.

  5. Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study 4/15/2025

    Discover how a clinical development program was saved using objective, continuous digital outcome measures.

  6. Partnership Driving Superior Enrollment And Speed In Phase III Trial 1/31/2025

    Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.

  7. 6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies 4/3/2025

    Real-world data (RWD) is transforming Colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.

  8. The Power And Potential Of RBM In Clinical Trials 11/8/2023

    Risk-based monitoring increases overall trial oversight by balancing “must-do” data collection and “nice-to-have” data against site and patient burden — and, more importantly, patient safety.

  9. Leveraging Real-World Data From The IRIS® Registry 7/8/2025

    With the FDA’s new Diversity Action Plan requirements, sponsors are now expected to set clear goals and strategies for enrolling diverse populations in clinical trials.

  10. Top 9 AI Implementation Strategies For Pharmacovigilance 6/18/2025

    By following these nine strategies, organizations can implement AI in pharmacovigilance responsibly, ensuring systems that are aligned with the goal of improving patient safety and public health outcomes.